Cancer Drug Reduced Relapses in MS Patients: Studies

Avatar for cmkarla
Administrator
Registered: 01-03-2001
Cancer Drug Reduced Relapses in MS Patients: Studies
Thu, 11-01-2012 - 9:59am

A little good news for MS patients according to this Health Day News article, "The cancer drug alemtuzumab (Campath) reduces the risk of disease relapse in people with multiple sclerosis, two new trials show.About 85 percent of multiple sclerosis patients start with a form of the disease called relapsing-remitting MS, where symptoms appear sporadically (a relapse) and then either partially or completely fade away. There is no cure for MS, and existing drugs only aim to reduce the symptoms of the disease." more

Your thoughts?

Karla
Community ModeratoriVillage.com